[Diagnosis and Treatment Protocol for COVID-19 from Military Medical Team Supporting Wuhan (Trial Version 2)]

Zhonghua Jie He He Hu Xi Za Zhi. 2020 May 12;43(5):414-420. doi: 10.3760/cma.j.cn112147-20200315-00338.
[Article in Chinese]

Abstract

With the update of the "Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia" from the National Health Commission of China, the military medical expert group on the front-line has formulated the "Diagnosis and Treatment Protocol for COVID-19 from Military Medical Team Supporting Wuhan(Trial Version 2)" . It provides some additional comments on the national protocol including disease name, virus origin, population susceptibility, interpretation of serum-specific antibody test results, evaluation of outbreak outcome and so on.

随着国家卫生健康委员会《新型冠状病毒肺炎诊疗方案》的更新,按军队前方指挥协调组的要求,军队前方专家组制定了《军队支援湖北医疗队新型冠状病毒病诊疗方案试行第二版》。在疾病名称、病毒起源、人群易感性、血清特异性抗体测定结果判读、疫情转归评估等十余处,对国家方案提出了补充意见,供广大读者参考。.

Keywords: Diagnosis and treatment protocol; Infections; Medical team; Military; Novel coronavirus.

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • China
  • Clinical Protocols
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / therapy
  • Humans
  • Military Personnel*
  • Pandemics*
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / therapy
  • SARS-CoV-2